鼻咽癌根治性治疗10年后出现的罕见腮腺晚期转移
An Unusual Late Parotid Metastasis of Nasopharyngeal Carcinoma 10 Years After Curative Treatment.
作者信息
Werda Majd, Laajailia Rania, Ben Amar Chadha, Walha Omar, Charfeddine Ilheme
机构信息
ENT- Head and Neck Department, Habib Bourguiba University Hospital, Sfax, Tunisia.
ENT- Head and Neck Department, Marsa Hospital, Tunis University of Medicine, Tunis, Tunisia.
出版信息
Indian J Otolaryngol Head Neck Surg. 2025 Jul;77(7):2700-2703. doi: 10.1007/s12070-025-05573-7. Epub 2025 May 20.
Abstract
We report a rare case of late parotid metastasis from undifferentiated nasopharyngeal carcinoma (NPC) occurring 10 years post-chemoradiotherapy. Despite negative EBV status, negative biopsies and inconclusive cytology, histopathology confirmed recurrence. The case underscores the challenging diagnosis of post-treatment NPC late metastases and emphasizes the need for vigilance in similar cases.
摘要
我们报告了一例罕见的未分化鼻咽癌（NPC）放疗化疗后10年出现腮腺晚期转移的病例。尽管EBV状态为阴性、活检结果为阴性且细胞学检查结果不明确，但组织病理学确诊为复发。该病例凸显了治疗后鼻咽癌晚期转移的诊断挑战，并强调了对类似病例保持警惕的必要性。
相似文献
1
An Unusual Late Parotid Metastasis of Nasopharyngeal Carcinoma 10 Years After Curative Treatment.
Indian J Otolaryngol Head Neck Surg. 2025 Jul;77(7):2700-2703. doi: 10.1007/s12070-025-05573-7. Epub 2025 May 20.
2
Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens.
BMC Cancer. 2025 Jul 1;25(1):1126. doi: 10.1186/s12885-025-14539-5.
3
Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review.
Oral Oncol. 2022 Oct;133:106031. doi: 10.1016/j.oraloncology.2022.106031. Epub 2022 Jul 28.
4
Long-term immune checkpoint inhibitor therapy in a patient with metastatic nasopharyngeal carcinoma: a case report.
Front Immunol. 2025 Jun 12;16:1585844. doi: 10.3389/fimmu.2025.1585844. eCollection 2025.
5
Solitary splenic metastasis from nasopharyngeal carcinoma: a case report and systematic review of the literature.
World J Surg Oncol. 2016 Jul 15;14(1):184. doi: 10.1186/s12957-016-0941-2.
6
Immunotherapy combined with chemotherapy without locoregional radiotherapy in metastatic nasopharyngeal carcinoma: two case reports and a literature review.
Front Immunol. 2025 Jan 9;15:1467355. doi: 10.3389/fimmu.2024.1467355. eCollection 2024.
7
Machine learning for predicting distant metastasis in nasopharyngeal carcinoma patients.
Front Immunol. 2025 Jun 5;16:1580200. doi: 10.3389/fimmu.2025.1580200. eCollection 2025.
8
IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells.
PLoS Pathog. 2025 Jun 26;21(6):e1013236. doi: 10.1371/journal.ppat.1013236. eCollection 2025 Jun.
9
Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations.
Asian Pac J Cancer Prev. 2012;13(6):2577-81. doi: 10.7314/apjcp.2012.13.6.2577.
10
Exploring the interplay between EBV and autophagy-related gene expression patterns in nasopharyngeal carcinoma.
Front Oncol. 2025 Jun 24;15:1588921. doi: 10.3389/fonc.2025.1588921. eCollection 2025.
本文引用的文献
1
Predicting distant metastasis in nasopharyngeal carcinoma using gradient boosting tree model based on detailed magnetic resonance imaging reports.
World J Radiol. 2024 Jun 28;16(6):203-210. doi: 10.4329/wjr.v16.i6.203.
2
MRI-based deep learning model predicts distant metastasis and chemotherapy benefit in stage II nasopharyngeal carcinoma.
iScience. 2023 May 19;26(6):106932. doi: 10.1016/j.isci.2023.106932. eCollection 2023 Jun 16.
3
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
Curr Treat Options Oncol. 2023 Sep;24(9):1138-1166. doi: 10.1007/s11864-023-01101-3. Epub 2023 Jun 15.
4
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance.
Nat Commun. 2023 Feb 4;14(1):610. doi: 10.1038/s41467-023-35995-2.
5
Deep Learning for Predicting Distant Metastasis in Patients with Nasopharyngeal Carcinoma Based on Pre-Radiotherapy Magnetic Resonance Imaging.
Comb Chem High Throughput Screen. 2023;26(7):1351-1363. doi: 10.2174/1386207325666220919091210.
6
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.
JAMA Oncol. 2022 Sep 1;8(9):1301-1309. doi: 10.1001/jamaoncol.2022.2810.
7
A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma.
Nat Commun. 2022 May 30;13(1):2996. doi: 10.1038/s41467-022-30709-6.
8
Prognostic analysis of 152 patients with distant metastasis after intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Ann Palliat Med. 2021 Jun;10(6):6824-6832. doi: 10.21037/apm-21-1279. Epub 2021 Jun 16.
9
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Lancet. 2021 Jul 24;398(10297):303-313. doi: 10.1016/S0140-6736(21)01123-5. Epub 2021 Jun 7.
10
A Nomogram for Predicting Distant Metastasis Using Nodal-Related Features Among Patients With Nasopharyngeal Carcinoma.
Front Oncol. 2020 May 29;10:616. doi: 10.3389/fonc.2020.00616. eCollection 2020.
Zotero 插件